AgenoLab - Your "Gold Standard" Contract Laboratory in Life Science and Biotechnology
Our Activities
GMP-Production
Our Services
In 2008 Agenolab GmbH & Co. KG acquired the technology to produce autologous skin transplants (KeraSeed®). This product can be used for the treatment of burn victums (plastic surgery) or for treating patients suffering from chronic wounds. Data of a multicenter clinical trial (Phase IIb/III) have been published in 2007.
In addition, Agenolab GmbH & Co. KG has access to the technology to produce autologous melanocytes for the treatment of Vitiligo patients.
Both products are regulated according to the Advanced Therapy Medicinal Product Regulation (1394/2007/EU). To treat patients the requirements outlined in the German Drug law, the German Tissue law have to be fulfilled.
For further informations please use the Contact form.
• GMP compliant production of autologous keratinocytes and melanocytes
• GMP compliant production of cell culture medium
• Sterility testing according to Ph. Eur.
• GMP compliant production of cell culture medium
• Sterility testing according to Ph. Eur.
Exhibition / News
New REGiNA Homepage
CPhI, Paris, 5.-7. October 2010
SEPAWA Congress and European Detergents Conference, Fulda, 13.-15. October 2010
BioStar 2010, 4th Congress on Regenerative Biology and Medicine, Stuttgart, 13.-15. October 2010
And the winner is: Agenolab GmbH!
CPhI, Paris, 5.-7. October 2010
SEPAWA Congress and European Detergents Conference, Fulda, 13.-15. October 2010
BioStar 2010, 4th Congress on Regenerative Biology and Medicine, Stuttgart, 13.-15. October 2010
And the winner is: Agenolab GmbH!
Job Advertisment
At the moment we are not looking for new employees
Our Company
Research
product development
methodology development
hardware check
Regenerative Medicine
methodology development
hardware check
Regenerative Medicine